Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68071-5020

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68071-5020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 5020 9)

NuCare Pharmaceuticals, Inc. label for Venlafaxine Hydrochloride 150 mg extended-release capsules. The label shows NDC 68071-5020-9 with a package size of 90 capsules. It includes standard storage instructions, warnings to keep out of reach of children, and directs to see the manufacturer's label for the full list of ingredients.*

FDA Label Image

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)

A pharmacokinetic chart showing the fold change and 90% confidence interval of venlafaxine and its metabolite ODV when co-administered with various interacting drugs. The x-axis represents the change relative to the reference value, and the y-axis lists interacting drugs such as Ethanol, Diazepam, Cimetidine, several CYP2D6 inhibitors, Indinavir, Metoprolol, Imipramine, and Lithium. Recommendations based on these interactions are provided on the right side, ranging from dose adjustments to cautionary use notes.*

FDA Label Image

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)

A pharmacokinetic fold change chart showing the effect of various interacting drugs on the analyte concentrations (Cmax and AUC) relative to a reference value. The chart includes drugs such as ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine and others, with markers indicating the fold change and 90% confidence intervals, alongside recommendations for dose adjustments or cautions for use.*

FDA Label Image

Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)

A pharmacokinetic chart showing the fold change and 90% confidence interval for venlafaxine in special populations, including hepatic (various impairment levels), renal (mild/moderate impairment and hemodialysis), CYP2D6 polymorphism, age over 60, and gender. The chart compares Cmax, AUC, and ODV parameters relative to reference values, alongside dosing recommendations for each group.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride, showing its molecular formula with labeled functional groups and atoms associated with the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.